Back
Akero Therapeutics Stock Price Chart
Sponsored
AKRO
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
AKRO
Akero Therapeutics
Last Price:
$28.56
Seasonality Move:
-9.11%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.08 | Sell |
20-day SMA: | 30.32 | Sell |
50-day SMA: | 30.79 | Sell |
200-day SMA: | 25.9 | Buy |
8-day EMA: | 29.2 | Sell |
20-day EMA: | 29.93 | Sell |
50-day EMA: | 30.02 | Sell |
200-day EMA: | 27.83 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.59 | Sell |
Relative Strength Index (14 RSI): | 41.92 | Sell |
Chaikin Money Flow: | -387199 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.23 - 31.69) | Sell |
Bollinger Bands (100): | (26.11 - 31.31) | Sell |
Akero Therapeutics Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 28.37 while AKRO 8-day simple moving average is 29.08, which is a Sell signal.
-
The stock price of AKRO is 28.37 while Akero Therapeutics 20-day SMA is 30.32, which makes it a Sell.
-
Akero Therapeutics 50-day simple moving average is 30.79 while AKRO share price is 28.37, making it a Sell technically.
-
AKRO stock price is 28.37 and Akero Therapeutics 200-day simple moving average is 25.90, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Sell
25
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a SellThe current Akero Therapeutics [AKRO] share price is $28.37. The Score for AKRO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Akero Therapeutics Stock Info
Market Cap:
2B
Price in USD:
28.37
Share Volume:
906.5K
Akero Therapeutics 52-Week Range
52-Week High:
37.00
52-Week Low:
15.32
Sell
25
Akero Therapeutics (AKRO)
is a Sell
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?The Akero Therapeutics stock price is 28.37 USD today.
-
Will AKRO stock go up or go down?Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akero Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is overvalued.
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 28.37 while AKRO 8-day exponential moving average is 29.20, which is a Sell signal.
-
The stock price of AKRO is 28.37 while Akero Therapeutics 20-day EMA is 29.93, which makes it a Sell.
-
Akero Therapeutics 50-day exponential moving average is 30.02 while AKRO share price is 28.37, making it a Sell technically.
-
AKRO stock price is 28.37 and Akero Therapeutics 200-day simple moving average is 27.83, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
-
AKRO Moving Average Covergence Divergence (MACD) indicator is -0.59, suggesting Akero Therapeutics is a Sell
-
Akero Therapeutics Relative Strength Index (RSI) is 41.92, which suggest Akero Therapeutics is oversold
-
The Bollinger Bands (25) for Akero Therapeutics is (29.23 - 31.69), which suggest Akero Therapeutics is a Sell
-
The Bollinger Bands (100) for Akero Therapeutics is (26.11 - 31.31), which suggest Akero Therapeutics is a Sell
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.